Back to search

University of York

The Role of JAK2V617F-positive Endothelial Cells in Aberrant Haemostasis and Thrombosis

Abstract

dc:description.abstract

Patients with MPNs commonly experience complications caused by dysfunctional haemostasis and thrombosis. Patient treatment is limited and aimed at preventing these adverse events, typically by low-dose aspirin therapy. However, a subset of patients experience increased risk of bleeding diatheses and these patients are at an even greater risk for experiencing complications if they are treated with low-dose aspirin. Currently, there are no methods for stratifying MPN patients to distinguish those who are at risk for thrombosis or bleeding. In order to improve MPN patient treatment, a better understanding of the mechanisms behind haemostasis and thrombosis complications is required. Here, we investigate the mechanisms of JAK2V617F activation in endothelial cells and the effects of JAK2V617F on endothelial function.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of York
Year dc:date.issued
2016

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Cosgrove, Megan
Advisor dc:contributor.advisor
  • Hitchcock, Ian

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.701476

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Cosgrove, Megan. The Role of JAK2V617F-positive Endothelial Cells in Aberrant Haemostasis and Thrombosis. doctoral thesis, University of York, 2016.